Good day, and welcome to the Core Laboratories' Fourth Quarter 2024 Earnings Call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Larry Bruno, Chairman and CEO. Please go ahead.

Thanks, Dave. Good morning in the Americas. Good afternoon in Europe, Africa and the Middle East, and good evening in Asia Pacific. We'd like to welcome all of our shareholders, analysts and, most importantly, our employees to Core Laboratories' fourth quarter 2024 earnings call. This morning, I'm joined by Chris Hill, Core's Chief Financial Officer; and Gwen Gresham, Core's Senior Vice President and Head of Investor Relations. The call will be divided into six segments. Gwen will start by making remarks regarding forward-looking statements. We'll then have some opening comments, including a high-level review of important factors in Core's Q4 performance. In addition, we'll review Core's strategies and the three financial tenets that the company employs to build long-term shareholder value. Chris will then give a detailed financial overview and have additional comments regarding shareholder value. Following Chris, Gwen will provide some comments on the company's outlook and guidance. I'll then review Core's two operating segments, detailing our progress and discussing the continued successful introduction and deployment of Core Labs technologies, as well as highlighting some of Core's operations and major projects worldwide. Then we'll open the phones for a Q&A session. I'll now turn the call over to Gwen for remarks on forward-looking statements.

Before we start the conference this morning, I'll mention that some of the statements we make during this call may include projections, estimates and other forward-looking information. This would include any discussion of the company's business outlook. These types of forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to materially differ from our forward-looking statements. These risks and uncertainties are discussed in our most recent Annual Report on Form 10-K as well as other reports and registration statements filed by us with the SEC. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Our comments also include non-GAAP financial measures. Reconciliation to the most directly comparable GAAP financial measures is included in the press release announcing our fourth quarter results. Those non-GAAP measures can also be found on our website. With that, I'll pass the discussion back to Larry.

Thanks, Gwen. Moving now to some high-level comments about our fourth quarter and full year 2024 results. Core continued to execute its strategic plan of technology investments, targeted to both solve client problems and capitalize on Core's technical and geographic opportunities. Fourth quarter revenue was down just under 4% compared to Q3 of 2024. However, full year revenue saw an increase of 3%. In addition, while operating income and earnings per share were down sequentially, for full year 2024, the company's operating income was up 7% and earnings per share was up 9% compared to 2023. In Reservoir Description, revenue for the fourth quarter was down 2% compared to Q3 of 2024, but up 3% from Q4 of last year, reflecting the continued market demand for our global rock and fluid laboratory services. This year-over-year improvement occurred despite the ongoing trade sanctions and geopolitical conflicts in Russia, Ukraine and the Middle East that continued to negatively impact demand for laboratory services that are specifically tied to the assay of crude oil and derived products. These geopolitical factors and sanctions are still producing headwinds to both revenue growth and operating margins for Reservoir Description. Despite these hurdles, for the fourth quarter ex-items, operating margins in Reservoir Description were still strong at 16%, down sequentially by 110 basis points, but up year-over-year by 170 basis points as we continue to focus on operational efficiencies. In Production Enhancement, fourth quarter revenue was down 7% sequentially compared to Q3 of 2024 and roughly flat for the full-year 2024 versus 2023. Ex-items, fourth quarter 2024 operating margins in Production Enhancement were 4%. In 2024, the company did experience a higher level of international product sales compared to 2023. However, these were offset by a decline in US product sales, reflecting lower levels of onshore completion activity in 2024 compared to 2023. Completion Diagnostic services that were scheduled for 2024 in the Gulf of Mexico and were delayed by multiple hurricanes have now been rescheduled by our clients to early 2025. Despite lower US onshore completion activity, for the full year, demand for completion diagnostics was up nicely. In line with our stated financial strategy, after funding our dividend, Core continued to dedicate the majority of its free cash to paying down debt. During the fourth quarter, Core's net debt was reduced by nearly $12 million. This reduction in our outstanding net debt also decreased Core's leverage ratio to 1.31, down from 1.47 last quarter, eliminating approximately 10% of the company's outstanding debt compared to the end of Q3. This is the lowest Core's leverage ratio has been in the last eight years, marking another significant step in our pledge to strengthen our balance sheet and deleverage the company. In addition to paying our quarterly dividend, Core Lab returned excess free cash to our shareholders by repurchasing nearly 265,000 shares of company stock during the fourth quarter. We will continue to focus free cash on reducing debt and strengthening our balance sheet while evaluating other opportunistic uses of free cash to improve shareholder value. Lastly, for the full company, ex-items, for the full-year 2024, EPS was $0.87 per share, representing a year-over-year growth in earnings of 9%. As we look ahead, Core will continue to execute its key strategic objectives by, one, introducing new product and service offerings in key geographic markets, two, maintaining a lean-focused organization, and three, maintaining our commitments to deleveraging the company and returning excess free cash to shareholders. Now to review Core Lab's strategies and the financial tenants the company has used to build shareholder value over our 29-year history as a publicly-traded company. The interest of our shareholders, clients and employees will always be well served, at Core Lab's resilient culture, which relies on innovation, leveraging technology to solve problems and dedicated customer service. I'll talk more about some of our latest innovations in the operational review section of this call. While we continue to pursue opportunities, the company will remain focused on its three long-standing long-term financial tenets, those being to maximize free cash flow, maximize return on invested capital and returning excess free cash to our shareholders. I'll now turn it over to Chris for the detailed financial review.

Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. Additionally, during the fourth quarter of 2024, the company recorded an adjustment of $4.1 million for the write-down of certain assets and discontinued inventory items, as well as costs associated with further consolidation of operational facilities. The fourth quarter also includes a gain of $3.3 million on insurance proceeds received and the reversal of stock compensation expense for certain performance share awards, which did not vest. The comparison periods for the third quarter of 2024 and fourth quarter of 2023 also include items that were discussed in those calls and highlighted in our earnings release for those periods. These items have also been excluded from our discussion of the financial results today. You can find a summary of those items in the tables attached to our press release for the fourth quarter and full year of 2024. Now looking at the income statement, revenue was $129.2 million in the fourth quarter, down 4% compared to the prior quarter and up slightly year-over-year. The sequential decline was primarily associated with a decrease in US onshore activity. Additionally, our laboratory services associated with crude assay analysis have been adversely impacted in certain regions due to the ongoing conflicts in Ukraine, Russia and the Middle East. For the full year 2024, revenue was $523.8 million, up 3% year-over-year which was driven by growth in our service revenue and partially offset by a lower level of product sales. Of this revenue, service revenue, which is more international was $96.5 million for the quarter, down 2% sequentially and up 2% from last year. The decline in US land activity continued throughout the fourth quarter and into the first quarter of 2025. However, this was partially offset by improved activity on completion diagnostic projects in the Gulf of Mexico which were negatively impacted by storms in the third quarter. Although the ongoing geopolitical conflicts continue to negatively impact crude assay laboratory services in certain international regions, we continue to see growth for both our reservoir rock and fluid analysis as well as completion diagnostic services in several international regions. For the full year of 2024, service revenue of $388.2 million was up over 4% compared to $371.9 million in 2023. Product sales, which is equally tied to US and international activity was $32.7 million for the quarter, down 8% sequentially and down 2% from the fourth quarter of 2023. The sequential and year-over-year decrease in product sales was primarily due to a decline in the US onshore activity while product sales to international markets were flat sequentially, but increased 8% year-over-year. For the full year 2024, product sales of $135.6 million were down 2% from $137.9 million in 2023, which is primarily associated with the activity decline in the US onshore market. Moving on to cost of services, ex-items for the quarter was slightly below 76% of service revenue, comparable to the prior quarter and the same quarter in 2023. We will continue to see improvements in absorption of cost and utilization of our global laboratory network with growth in these services. However, the service side of our business has been more impacted by the geopolitical conflicts and associated sanctions. The volatility in crude oil prices and more recently expanded sanctions continue to cause disruptions to the trading and maritime movement of crude oil and derived products and the associated crude assay laboratory services that we provide. The company will continue to manage its cost structure as effectively as we can through these temporary disruptions in certain regions. For full year 2024, cost of services ex-items was below 77% of service revenue, which compared to 76% in 2023. Cost of sales ex-items in the fourth quarter was 90% of sales revenue, compared to 88% in the prior quarter and 91% in the same quarter in 2023. The increase this quarter is primarily due to reduced manufacturing efficiencies associated with lower US onshore sales. The company anticipates the US onshore activity levels will begin to improve as the first quarter of 2025 unfolds and reach similar levels compared to 2024. The company will continue to manage the business as efficiently as possible through this volatility in the US market. For the full year 2024, cost of sales ex-items was approximately 88% of sales revenue which compares to 85% in 2023. G&A ex-items for the quarter was $9.9 million, down slightly compared to the prior quarter. Full year 2024 G&A ex-item was $38.4 million compared to $36.6 million in the full year of 2023. For 2025, we expect G&A to be approximately $40 million to $44 million. It is also important to note that 100% of our corporate G&A expenses are allocated and absorbed into the financial performance of the reported segments. Depreciation and amortization for the quarter was $3.7 million and flat compared to the last quarter, but down compared to $3.9 million in the same quarter last year. EBIT ex-items for the quarter was $15.7 million, down $2.5 million from last quarter, yielding an EBIT margin of over 12%. Year-over-year EBIT ex-items for the fourth quarter was up slightly from last year. Our operating income for the quarter on a GAAP basis was $14.2 million. Full year 2024 EBIT ex-items was $65.3 million, up 7% from $61.2 million in 2023. And on a GAAP basis, EBIT was $58.6 million for 2024, compared to $54.6 million in 2023. Interest expense of $2.6 million decreased over 15% compared to $3.1 million in the prior quarter and decreased 27% compared to $3.6 million in the fourth quarter of last year. The decrease in interest expense is a direct result of the company's continued effort to reduce debt. Income tax expense at an effective tax rate of 20% and ex-items was $2.6 million for the quarter. On a GAAP basis, tax expense was $4.1 million for the quarter, and for the full year of 2024, income tax expense on a GAAP basis was $14 million compared to $4.2 million in 2023 and the lower tax expense in 2023 is primarily due to the tax benefit of $11.6 million associated with the redomestication transaction that was executed in 2023. Additionally, the company continues to evaluate and finalize tax planning associated with the new tax structure after redomesticating the parent company from the Netherlands to the US. For 2025, we project the company's effective tax rate to be approximately 25%. However, the effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and items that are discrete to each quarter. Net income ex-items for the quarter was $10.4 million, down from $11.8 million in the prior quarter but up from $8.9 million in the same quarter last year. On a GAAP basis, we recorded net income of $7.4 million for the quarter. For the full year 2024, net income ex-items was $41.6 million, up 10% from $37.8 million in 2023. GAAP net income for the full year of 2024 was $31.4 million. Earnings per diluted share ex-items was $0.22 for the quarter, down from $0.25 in the prior quarter but up from $0.19 in the same quarter last year. On a GAAP basis, earnings per diluted share was $0.15 for the quarter. And for the full year 2024, earnings per diluted share ex-items was $0.87, up 9% from 2023. And on a GAAP basis, full year 2024 EPS was $0.66. Turning to the balance sheet. Receivables were $111.8 million, which decreased approximately $5.8 million from the prior quarter. Our DSOs for the fourth quarter were at 76 days compared to 74 days in the prior quarter. Inventory was $59.4 million as of December 31st, a decrease of approximately $6.1 million from last quarter end and down $12.3 million from the end of last year. Inventory turns for the quarter improved to 2.1 from 1.9 in the last quarter and have continued to improve over the last few quarters. Despite a challenging US onshore market this quarter, our team did a nice job remaining focused on our inventory management and we will remain focused on these efforts as we continue to look for improvement in 2025. Now to the liability side of the balance sheet. Our long-term debt was $128 million at December 31st 2024, a reduction of $14 million this quarter. Considering cash of $19.2 million, net debt was $108.8 million, a decrease of $11.7 million from $120.5 million at the end of the prior quarter. For 2024, net debt was reduced by $42 million or 28% from the end of last year. Additionally, our leverage ratio continued to improve throughout 2024 and decreased from 1.76 last year end to 1.31 at December 31st 2024. As Larry mentioned earlier, this is the lowest our leverage ratio has been in over eight years. Our debt is currently comprised of our senior notes at $110 million and $18 million outstanding under our bank credit facility. Our credit facility has a borrowing capacity of $135 million of which approximately $106.1 million was still available as of December 31st 2024. Since announcing the company's commitment and focus on reducing debt in the fourth quarter of 2019, we have reduced net debt by 63%. The company will remain focused on executing its strategic business initiatives while continuing to apply free cash towards reducing debt and lowering the leverage ratio. Looking at cash flow for the fourth quarter of 2024, cash flow from operating activities was $20.6 million and after paying for $4.4 million of CapEx during the quarter, our free cash flow was $16.2 million. For the full year 2024, cash flow from operating activities was $56.4 million and capital expenditures totaled a little over $13 million. From this, the company generated free cash flow of $43.4 million, a significant improvement from $14.2 million in 2023. Looking ahead to 2025, we will continue to manage investment in working capital during a period of growth and continue our capital discipline with capital expenditures primarily targeted at growth opportunities. However, our capital expenditures are expected to be elevated as the rebuilding of our Aberdeen facility that was damaged by a fire in February of 2024 is planned for 2025. Capital expenditures associated with restoring this facility is estimated to be between $10 million and $12 million. However, these investments are covered by insurance proceeds either received in 2024 or to be received in 2025. The company will report the CapEx associated with rebuilding the Aberdeen facility separately. So excluding the Aberdeen facility, we expect capital expenditures in 2025 to be in the range of $15 million to $17 million. Core Lab's global laboratory network and intellectual property continue to provide operational leverage and the ability to grow revenue and profitability with minimal capital requirements. Additionally, we continue to improve the efficiencies in our global laboratory infrastructure through some consolidation of operations and investments in automation. Capital expenditures have historically ranged from 2.5% to 4% of revenue even during periods of significant growth. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing and projecting company's financial results, particularly for those shareholders who utilize discounted cash-flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.

Thank you, Chris. As 2025 begins, Core will continue to implement its strategic plan for technology investments aimed at addressing client challenges and leveraging Core's growth opportunities. Operators have taken a cautious approach in the second half of 2024 due to concerns about a possible imbalance in crude oil supply and demand. However, we remain optimistic about long-term international upstream projects for 2025 and beyond. According to the IEA, EIA, and OPEC+, crude oil demand is projected to grow by approximately 1.1 million to 1.4 million barrels per day in 2025, in addition to the natural decline from existing production. This necessitates ongoing investment in developing onshore and offshore crude oil fields to meet that demand. In the near-term, we anticipate continued volatility in crude oil markets because of global economic uncertainties and geopolitical risks. In January 2025, expanded sanctions affected the maritime trade of crude oil and related products, along with the demand for essential laboratory services and restricted product sales to a larger group of entities. In line with this outlook, Core will maintain active involvement in long-cycle international projects. Looking ahead, steady international project activity, particularly from the South Atlantic margin, North and West Africa, Norway, the Middle East, and some areas of Asia Pacific, should support mid-single-digit year-over-year growth and demand for Core Lab services and products. In the US, onshore activity is anticipated to remain flat or decline slightly compared to 2024. Besides geopolitical risks and the recent sanctions, we predict standard seasonal industry patterns will lead to decreased activity in the first quarter of 2025 in certain regions. Severe weather in the US and the Mediterranean has resulted in halted client activities and facility closures. Consequently, Core projects that Reservoir Description's first-quarter revenue will range from $82 million to $85 million with operating income of $9 million to $10.7 million. The first-quarter 2025 onshore US drilling and completion activity was negatively impacted by freezing conditions and continued to decrease throughout January. However, we expect activity to improve as the quarter progresses. As a result, Production Enhancement's first-quarter revenue is projected to range from $39 million to $42 million with operating income of $1.1 million to $2 million. The company's overall first-quarter revenue is expected to range from $121 million to $127 million with operating income of $10.2 million to $12.8 million, leading to operating margins of approximately 9%. Core's effective tax rate is estimated at around 25% for 2025. This change in the effective tax rate is likely to increase income tax expenses for the first quarter of 2025 by about $500,000. Therefore, EPS for the first quarter is anticipated to fall between $0.12 and $0.16. The company's first-quarter 2025 guidance is based on underlying operations and excludes gains and losses from foreign exchange. I'll now hand the call back to Larry.

Thanks, Gwen. First, I'd like to thank our global team of employees for providing innovative solutions, integrity and superior service to our clients. The team's collective dedication to servicing our clients is the foundation of Core Lab's success. Looking at the macro, as Gwen mentioned, after assessing current and near-term economic conditions, recent IEA, EIA, and OPEC projections are forecasting growth in global crude oil demand of between 1.1 million barrels and 1.4 million barrels per day for 2025 compared to 2024. This projected growth in demand is in addition to the production that needs to be brought online to account for the natural decline from existing producing fields. Furthermore, the EIA is forecasting US oil production to only rise from 13.2 million barrels per day in 2024 to 13.5 million barrels per day in 2025. Excluding the COVID period, year-over-year growth of only 300,000 barrels per day would represent the smallest annual add to US oil production since 2018. In addition, the most recent EIA forecast projects that US production growth will rise to only 13.6 million barrels per day in 2026, an increase of just 100,000 barrels per day. US tight oil production has been by far the largest component of non-OPEC production growth since 2010. Continued growth in global oil demand combined with slowing year-over-year US oil production growth supports the thesis that future crude oil demand will be largely met from international, conventional, offshore discoveries and developments, all trends that bode well for increasing demand for reservoir description services, a pattern that we project will play out for the next several years. Production enhancement, in addition to its exposure to the US land market, also has expanding opportunities in international markets such as with unconventional plays in the Middle East and emerging onshore and offshore conventional plays in a number of regions. Core Lab also continues to expand its portfolio of innovative offerings for perforating applications, plug-in abandonment operations and completion diagnostics. In addition, in 2024, Core Lab opened a completion diagnostics lab in the Middle East to better serve the opportunities in that region. Now let's review the fourth quarter performance of our two business segments. Turning first to Reservoir Description. For the fourth quarter of 2024, revenue came in at $86.8 million, down 2% compared to Q3. For Q4, operating income for Reservoir Description ex-items was $14.1 million, down from $15.4 million in Q3, but operating margins were still strong at over 16%, slightly below the 17% achieved in Q3 of 2024. While demand for Reservoir Description lab services remained strong across our global network, demand softened in the US market in line with reduced US land activity and headwinds persisted from international geopolitical conflicts and associated sanctions. These geopolitical conflicts and sanctions detracted from growth trends that are occurring across other regions. Now for some operational highlights from Reservoir Description. During the fourth quarter of 2024, a leading Middle East offshore operator engaged Core Lab's formation damage team to address challenges related to the reinjection of produced water from a mature field. Cost-effective and environmentally sound disposal of produced water often influences the return on investment that operators can achieve from an oil and gas field. Core's team conducted advanced fluid compatibility and Core flooding experiments in the laboratory. These analytical results provided critical data for both the design of cost-effective water treatment facilities and the optimization of the operator's reinjection strategies. Specifically, these tests determine the need for filtration and chemical treatment strategies and also identified the most favorable injection rates. In addition, the lab results determined if the injected water would react adversely with either the in-situ formation water or the rocks. This project nicely illustrates how Core Labs reservoir Description services are required throughout the life cycle of oil and gas fields. Now to Production Enhancement, where Core Lab technologies continue to help our clients optimize their well completions and improve production. Revenue for Production Enhancement for Q4 came in at $42.4 million, down 7% compared to Q3 and down 3% year-over-year. Fourth-quarter operating income for Production Enhancement ex-items was $1.5 million, yielding operating margins of 4%. For the full year, revenue was $178 million and operating income ex-item was $12 million, down 16% compared to 2023. Production Enhancement did achieve both slightly higher levels of international product sales, up 1.1% as well as growth in demand for completion diagnostic services, which were up 15%, largely reflecting improved market penetration of innovative technology offerings in the US. However, product sales in the US did feel the impact of reduced US land completion activity. Now for operational highlights for Production Enhancement. During the fourth quarter of 2024, Core Lab continued to build on the success of its refrac energetic technologies for mechanical isolation and recompletions in unconventional reservoirs. Recompletions allow operators to extend the productive life of their well inventory by implementing techniques that isolate previously produced intervals before accessing untapped reservoir sections between the previously completed stages of a horizontal well. Several North American operators approached Core Lab's ballistic engineers to design fit-for-purpose energetic solutions for recompletions. Conventional shape charges would provide inferior performance, leading to lower frac efficiencies and reduced stimulated reservoir volumes in the new stages. Core Labs experts developed proprietary ballistics to overcome the completion challenges presented in these mechanical isolation recompletions, which include the penetration of multiple downhole casing strings. In recompletions that used Core's proprietary refrac technology, operators reported approximately 50% improved hydraulic fracturing efficiencies, leading to significantly higher hydrocarbon recovery rates. Also in the fourth quarter, Core's completion diagnostic technologies were used by a deepwater Gulf of Mexico operator who sought Core's help to confirm the competency of their frac pack completion. To do so, Core employed its SPECTRASTIM proppant tracing, SPECTRASCAN gamma ray logging, and PACKSCAN technologies. The diagnostic data showed sufficient profit reserve above the top of the sand control screen, but a complete absence of probe across the lower third of the screen. Core's engineering team was able to identify that formation fines had entered the annulus prior to the frac pack. The daily drilling reports revealed that numerous tubing movements had occurred while pumping the frac pack. Core's diagnostic experts and the operator's completions team agree that the excess tubing movements had drawn formation fines into the annulus. The operator chose to set a plug of the tubing above the formation material and proceed with production operations, thus preventing an expense of completion failure. That concludes our operational review. We appreciate your participation, and Dave will now open the call for questions.

We will now begin the question-and-answer session. Our first question comes from Stephen Gengaro with Stifel. Please go ahead.

Thanks. Good morning, everybody.

Good morning, Steve.

I probably ask you this almost every quarter, but when we think about production enhancement in the US market, how do you view the competitive dynamics and pricing environment? We've recently heard that the oriented perf guns are significantly improving production. I'm curious about your perspective on that market and how you might be able to capture more value for the benefits you provide.

Yes. Well, look, it's a crowded market, Steve. We've talked about this with you and across our conversations. It's a crowded market with a lot of competition. And you've got some buyers that want to pay for technology and performance and you've got some buyers that want commodity products. And so, we're going to always try to aim ourselves at technology advantages that differentiate our projects. So I'd say, we've seen stable pricing in that market. I wish it was higher and we were getting rewarded more for that technology. But with so much capacity in that space, I think that it's going to weigh on everybody that's playing in that market.

Okay. Great. Thanks. Can you discuss the international R&D business and what you're observing regarding pricing? Also, when you consider 2025, what do you believe will be the main drivers of that business?

Yes, I think we should separate what we are experiencing in the first quarter from what we incorporated into our forecast for that period. Typically, we see a seasonal drop from the fourth quarter to the first quarter in reservoir description operations, influenced in part by weather conditions. Recently, severe weather led to some closures along the Gulf Coast, which impacted operations even more. This situation is compounded by a usual seasonal trend in client activity that reduces our description work. Furthermore, the sanctions announced on January 10th significantly affected both segments of our business, particularly product sales to Eastern Europe and laboratory work related to crude oil assays necessary for trading and transportation. A number of ships were barred from the market, causing trading activity to pause and reducing demand for our lab services as clients navigated the sanctions. This situation is a key factor in our outlook for the first quarter. Looking ahead for the rest of the year, we still expect reservoir description to increase by mid-single digits. Our international activity remains robust, and project progression looks promising. We feel more optimistic about international activity related to reservoir description than some others in the industry. We do not anticipate any pricing decline, and in fact, we expect pricing for reservoir description to rise by mid-single digits year-over-year.

Great. Thank you for the color.

And the next question comes from Josh Jayne with Daniel Energy Partners. Please go ahead.

Hey, Josh.

Thanks, good morning. First question, I just wanted to dig into that a little bit more going back to the mid-single digit activity increase internationally. Maybe you guys could give a bit more detail walking through the world through your international markets, where you're seeing the most growth and where things may be more muted over the course of 2025?

We tend to not be a leading indicator of what's happening in the sector, especially in reservoir description. Our projects often reflect a lagging response both on the way up and down. Some companies involved in well construction may notice early increases in activity, but then things slow down for them. Currently, we are in a constructive phase related to formation evaluation, particularly in the Middle East, where we have projects in multiple countries that are just beginning. We believe these projects have strong potential. The South Atlantic margin also looks promising, although we've seen some clients in West Africa and the South Atlantic report dry wells, which will affect our work over time as they didn't find the sand or hydrocarbons they were expecting. Despite this, we remain optimistic about the South Atlantic margin in the coming years. For the Middle East and Asia Pacific, we are particularly positive about opportunities in Australia and Indonesia. Project work in the North Sea, especially on the Norway side, appears strong as well. However, we are not active in Mexico and believe that stepping away from that market will benefit us in the near term. We will still sell products for service in Mexico if approached but are no longer operationally involved there.

Thanks for all that detail, I appreciate it. Second question is more of a shorter-term, but I just want to get a bit of a grasp on it a little bit, which is the Q1 weather. Could you just talk about where exactly you saw the largest impact, how many days you were ultimately down? I know you talked about Gulf Coast and office closures and I know we felt some of it in Houston. But maybe you could just go into that a little bit more so the industry could have a better idea of where we stood over the course of Q1? Thanks.

Our main product manufacturing facility is located in Godley, Texas. We experienced about two and a half days of closures due to freezing weather. Our largest laboratory facility in Houston was also closed for a couple of days. On the reservoir description side, laboratories near the Texas and Louisiana border, specifically in the Beaumont-Port Arthur area and extending into New Orleans and Broussard, had approximately three days of closures. Overall, we faced multiple days of shutdowns at the beginning of the quarter. Some ports that manage shipping for our laboratory analytical work on crude assays were also closed, leading to disruptions. In total, these closures affected around $1 million in revenue, with significant incremental impacts, as we retained all of our employees and staff. Additionally, we had a few closures in the Mediterranean region.

Thank you very much. I'll turn it back.

Our next question comes from David Smith with Pickering Energy Partners. Please go ahead.

Hey, thank you for taking my question. Good morning. Congratulations on the strong Q4 free cash flow and the balance sheet progress.

Yes, thanks.

Thank you.

Following up on the commentary for the full year outlook on reservoir description. I guess first, I did want to ask if it's fair to think that maybe it's the geopolitical disruptions having an outsized impact on the decremental margins for reservoir description in Q1?

No question about that, Dave. And I guess we can all take our view of what's going to happen with the sanctions. I will say, we didn't see the expansion that was announced on January 10th, but it had immediate impact on both segments of our business. Like I said, product shipments into Eastern Europe, that won't go through in Q1. We think it will come back if the sanctions are withdrawn or pulled back. And then also on the crude assay work, it has a very quick effect on our profitability. So if those unwind and we think that to keep the price of oil where people are comfortable with it, we think they will unwind, then there's an opportunity for us to maybe claw some of that back later in the year. But right now, as we look at the first quarter, I just wanted to be open about those headwinds that emerged.

I appreciate it. So if reservoir description were up mid-single-digits and 2025 revenue was up, would you think that the almost 60% incremental margins from 2024 would be a good framework for 2025 after Q1 at least?

Yes, I believe so. This is not just a number for 2024; it's a longstanding metric. As our activity grows, this figure could potentially increase. Consider the fixed cost structure of our lab network; as we process more materials in Reservoir Description, achieving a 60% incremental margin is a solid benchmark. We typically discuss margins exceeding 50%, which I don't want to say is easily attainable, but it's regularly achievable. Last year, we were close to 60%, and if we see increased business, those margins could rise even further.

Great. Thank you very much.

Okay.

Okay. We'll wrap-up here. In summary, Core's operational leadership continues to position the company for improving client activity levels in the coming quarters. We have never been better operationally or technologically positioned to help our global client base optimize their reservoirs and to address their evolving needs. We remain uniquely focused and are the most technologically advanced client-focused reservoir optimization company in the oilfield sector. The company will remain focused on maximizing free cash and returns on invested capital. In addition to our quarterly dividends, we'll bring value to our shareholders via growth opportunities, driven by both the introduction of problem-solving technologies and new market penetration. In the near term, Core will continue to use free cash to strengthen its balance sheet, while always investing in growth opportunities and evaluating various methods to increase shareholder value, including returning excess free cash to our shareholders. So in closing, we thank and appreciate all of our shareholders and the analysts that cover Core Lab. The executive management team and the Board of Core Laboratories give a special thanks to our worldwide employees that have made these results possible. We're proud to be associated with our continuing achievements. So thanks for spending time with us and we look forward to our next update. Goodbye for now.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.